U.S. Capital Markets Stock News

Dimeco (DIMC) posted a robust set of earnings, as its net profit margin climbed to 32.2% from last year’s 27.6%. Earnings growth accelerated to 36.1% year-over-year, far outpacing the 6.7% average annual growth of the past five years. Shares are trading at $41.25, which is well below the estimated fair value of $93.21. The company’s 6.8x Price-To-Earnings ratio is significantly lower than both peer and industry averages. With no major risks reported and a backdrop of attractive dividends and...

Betterware de México (NYSE:BWMX) reported a net profit margin of 7.2%, a jump from last year's 6.4%, with recent earnings up 15.8%. Analysts expect annual earnings growth of 26.99% going forward, outpacing the US market’s expected 15.5% growth, even as revenue is projected to rise by 5.8% per year. With BWMX trading at just 9x earnings, well below industry and peer averages, and shares priced at $13.35, investors are seeing the kind of profit growth and value metrics that often draw attention...

WD-40 (WDFC) reported a net profit margin of 14.7%, up from 11.8% the previous year, with earnings increasing 31.1% over the last twelve months. This growth is significantly higher than its five-year average growth rate of 3.6% per year. Shares are trading at $202.43, well above the estimated fair value of $32.29, and the company’s price-to-earnings ratio of 30.1x is well above peer and industry averages. With high profitability quality, an attractive dividend, and a steady growth track...

ETHZilla Corporation recently completed a 1-for-10 stock split on October 20, 2025, and appointed John D. Kristoff as Senior Vice President, Corporate Communications and Investor Relations, reporting directly to Chairman and CEO McAndrew Rudisill. This combination of a share structure change and the creation of a high-level communications and investor relations role highlights ETHZilla's focus on expanding accessibility and strengthening its engagement with both investors and the...

Earlier this week, Alector and its partner GSK announced that latozinemab failed to meet safety and efficacy criteria in a Phase 3 clinical trial for frontotemporal dementia due to GRN gene mutations, leading to the discontinuation of related studies and a workforce reduction of approximately 49%. This setback not only impacts Alector's core pipeline but also coincides with the resignation of its President and Head of R&D, highlighting significant changes in the company's direction. We'll...

Fortrea Holdings Inc. ( NASDAQ:FTRE ) insiders who purchased shares in the last 12 months were richly rewarded last...

Valley National Bancorp (VLY) posted a notable uptick in profitability, with current profit margins at 26.6%, up from 22% a year ago. Earnings are forecast to grow 17.01% per year, outpacing the US market’s 15.5% annual rate. Revenue is expected to increase at 7.6% per year, which trails the 10% US average. With high-quality earnings, attractive dividends, and a recent 17.2% acceleration in earnings growth over the past year, the recent results signal continued momentum but leave investors...

Vimeo (VMEO) shares have quietly climbed in recent months, gaining over 90% in the past quarter. Investors seem to be taking a closer look at the company’s evolving business and recent annual growth figures. See our latest analysis for Vimeo. After a long stretch of mixed sentiment, Vimeo’s recent share price return of over 90% in the past quarter reflects renewed optimism and upward momentum. This is especially notable considering its 65% total shareholder return over the past year. While...

In recent days, Flux Power Holdings, Inc. filed a shelf registration statement to potentially offer up to US$19.57 million in common stock, comprising 3,644,289 shares. This move gives the company financial flexibility, potentially signaling preparations for future capital needs, business development plans, or expansion opportunities. We'll examine how the shelf registration could affect Flux Power Holdings' narrative, especially its impact on future funding and growth plans. Find companies...

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

We can readily understand why investors are attracted to unprofitable companies. For example, Telos ( NASDAQ:TLS...

Key Insights Institutions' substantial holdings in Voyager Therapeutics implies that they have significant influence...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Simpson Manufacturing Co., Inc. ( NYSE:SSD ), is not the largest company out there, but it saw a decent share price...

ICON (ICLR) has delivered solid earnings, growing its profits by 27.1% per year on average over the past five years, with the most recent year showing 11.2% earnings growth. Net profit margins improved to 9.8% from last year’s 8.6%, and future earnings are forecast to rise by 10.97% annually. Backed by these positive trends in earnings quality and sustained margin expansion, investors are looking at a company with underlying strength and favorable valuation signals. See our full analysis for...

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...

Ardagh Metal Packaging (AMBP) remains unprofitable, with losses having deepened at a rate of 15.2% per year over the past five years. Looking ahead, analysts expect the company to turn things around within the next three years, projecting 92.65% annual earnings growth and a 3% yearly revenue climb. However, that is slower than the broader US market’s anticipated 10% pace. For investors, the combination of forecasted profit potential and the company’s value pricing is likely to keep AMBP in...

Tesla (TSLA) reported a net profit margin of 5.3%, down from last year’s 13.3%, as the company saw negative earnings growth over the most recent year despite averaging 19.2% annual earnings growth over the past five years. Still, the outlook remains upbeat, with revenue forecast to rise 16.9% per year and earnings expected to surge by 36% annually, both easily outpacing broader US market averages. See our full analysis for Tesla. Up next, we’ll see how these results hold up against the major...

Reliance (NYSE:RS) posted net profit margins of 5.2%, down from 7.4% a year ago, highlighting a decrease in profitability. While the company’s earnings have grown at just 0.9% per year on average over the past five years, forecasts now call for earnings growth of 11.1% per year and revenue to expand by 3% annually. Recent margin compression and slower profit acceleration set the stage for investors to weigh the company’s high earnings quality and attractive dividend against shifting growth...

Origin Bancorp (NYSE:OBK) reported net profit margins of 20.5%, down from 23.5% a year ago. Earnings have risen at an annual rate of 3.7% over the past five years. Shares currently trade at $33.09, which is well below the company’s estimated fair value of $59.93. Looking ahead, OBK’s earnings are forecast to grow at 19.8% per year, which is above the broader US market expectation of 15.5% annual growth. However, with revenue growth projected to lag the market and margins coming under...

Crown Castle (CCI) remains unprofitable, with net losses rising at a steep 47% annual pace over the past five years. Looking ahead, revenue is projected to fall by 9.1% per year for the next three years, but earnings are expected to rebound sharply, growing by nearly 90% annually as the company moves toward profitability. As the market weighs ongoing profitability risks against strong earnings growth forecasts, the focus is on whether Crown Castle can deliver on its turnaround potential amid...

Omnicom Group (OMC) is expected to grow earnings at 7.9% annually, building on its five-year track record of 5.6% per year. The company’s net profit margin slipped to 8.3% from last year's 9.5%, pointing to a bit of margin compression even as earnings quality remains high. See our full analysis for Omnicom Group. The next section takes a closer look at how these headline performance numbers measure up against the most-watched market narratives, highlighting where expectations hold up and...

Coya Therapeutics, Inc. has completed a follow-on equity offering worth US$20,000,002, issuing 3,636,364 shares of common stock at US$5.50 per share. This capital raise signals the company’s focus on securing funding for continued development of its therapeutic programs and growth initiatives. With fresh capital in hand, we'll examine how the follow-on equity offering influences Coya Therapeutics' investment narrative and funding outlook. The end of cancer? These 27 emerging AI stocks are...